Fdasia human drug review implementation
Ended Awarded Last action
- Contract number
- HHSF22318001
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $6,475,295
Award facts
- Opportunity
-
- Professional Service Schedule Solicitation · FCO00CORP0000C · Posted Jun 10, 2019
- Contract value 72% obligated
- $8,985,714.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,960 | |
| Exercise an Option | $5,398,192 | |
| Other Administrative Action | $0 | |
| Original award | $1,080,063 |
About this award
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to Booz Allen Hamilton Inc., a leading management and technology consulting firm, for the implementation of the FDA Safety and Innovation Act (FDASIA) Human Drug Review. The $8,985,714.89 award is a Blanket Purchase Agreement (BPA) call and covers a range of services including cybersecurity, data analytics, and operational support for the FDA's human drug review processes. The contract is not set aside.
Major subcontractors include Tailored Solutions & Consulting Inc., an SDVOSB cybersecurity firm, and Emprata LLC, a small business providing IT consulting services. These subcontractors are supporting the implementation of FDASIA by delivering capabilities such as cybersecurity data requirements, threat modeling, compliance monitoring, and software assurance. The overall FDASIA Support Services contract vehicle was previously established by the FDA to streamline procurement of critical services related to the agency's drug review and approval functions.
Quick answers
Who was awarded contract HHSF22318001?
HHSF22318001 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on March 12, 2018.
How much is contract HHSF22318001 worth?
The government has obligated $6,475,295 on HHSF22318001. Its current value, with exercised options, is $8,985,715.
Is contract HHSF22318001 an order under another contract?
Yes. HHSF22318001 is a BPA call under GS00F008DA-HHSF223201610017B, a blanket purchase agreement, on FDA Safety And Innovation Act Support Services (FDASIA).
Was contract HHSF22318001 competed?
The extent of competition for HHSF22318001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award